nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC22A3—Melphalan—breast cancer	0.128	0.363	CbGbCtD
Amphetamine—CYP2D6—breast cancer	0.125	1	CbGaD
Amphetamine—L-Phenylalanine—Melphalan—breast cancer	0.0966	0.405	CrCrCtD
Amphetamine—CYP2A6—Letrozole—breast cancer	0.0894	0.253	CbGbCtD
Amphetamine—Benzphetamine—Toremifene—breast cancer	0.087	0.365	CrCrCtD
Amphetamine—Benzphetamine—Tamoxifen—breast cancer	0.0546	0.229	CrCrCtD
Amphetamine—SLC22A3—Irinotecan—breast cancer	0.0433	0.123	CbGbCtD
Amphetamine—CYP2A6—Tamoxifen—breast cancer	0.0266	0.0755	CbGbCtD
Amphetamine—CYP2A6—Fluorouracil—breast cancer	0.0196	0.0556	CbGbCtD
Amphetamine—CYP2D6—Idarubicin—breast cancer	0.019	0.0538	CbGbCtD
Amphetamine—CYP2D6—Vinorelbine—breast cancer	0.00928	0.0263	CbGbCtD
Amphetamine—CYP2D6—Tamoxifen—breast cancer	0.00838	0.0237	CbGbCtD
Amphetamine—CYP2D6—Vinblastine—breast cancer	0.00572	0.0162	CbGbCtD
Amphetamine—CYP2D6—Doxorubicin—breast cancer	0.00351	0.00996	CbGbCtD
Amphetamine—CARTPT—pituitary gland—breast cancer	0.0021	0.0626	CbGeAlD
Amphetamine—CARTPT—female reproductive system—breast cancer	0.00192	0.0573	CbGeAlD
Amphetamine—TAAR1—female reproductive system—breast cancer	0.00192	0.0573	CbGeAlD
Amphetamine—CARTPT—adrenal gland—breast cancer	0.00187	0.0559	CbGeAlD
Amphetamine—CARTPT—endocrine gland—breast cancer	0.00163	0.0485	CbGeAlD
Amphetamine—CARTPT—lymph node—breast cancer	0.00112	0.0335	CbGeAlD
Amphetamine—SLC22A3—nipple—breast cancer	0.000929	0.0277	CbGeAlD
Amphetamine—MAOB—nipple—breast cancer	0.00086	0.0257	CbGeAlD
Amphetamine—SLC22A5—mammary gland—breast cancer	0.000817	0.0244	CbGeAlD
Amphetamine—SLC18A2—endometrium—breast cancer	0.000788	0.0235	CbGeAlD
Amphetamine—SLC22A3—embryo—breast cancer	0.000767	0.0229	CbGeAlD
Amphetamine—SLC18A2—uterus—breast cancer	0.000726	0.0217	CbGeAlD
Amphetamine—SLC18A2—adipose tissue—breast cancer	0.00071	0.0212	CbGeAlD
Amphetamine—MAOB—embryo—breast cancer	0.00071	0.0212	CbGeAlD
Amphetamine—SLC22A5—nipple—breast cancer	0.000676	0.0202	CbGeAlD
Amphetamine—SLC18A2—female reproductive system—breast cancer	0.000653	0.0195	CbGeAlD
Amphetamine—SLC18A2—adrenal gland—breast cancer	0.000637	0.019	CbGeAlD
Amphetamine—CYP2A6—adipose tissue—breast cancer	0.000634	0.0189	CbGeAlD
Amphetamine—SLC22A3—endometrium—breast cancer	0.000561	0.0167	CbGeAlD
Amphetamine—SLC18A2—endocrine gland—breast cancer	0.000552	0.0165	CbGeAlD
Amphetamine—MAOB—endometrium—breast cancer	0.000519	0.0155	CbGeAlD
Amphetamine—SLC22A3—adipose tissue—breast cancer	0.000506	0.0151	CbGeAlD
Amphetamine—MAOB—uterus—breast cancer	0.000478	0.0143	CbGeAlD
Amphetamine—MAOB—pituitary gland—breast cancer	0.00047	0.014	CbGeAlD
Amphetamine—MAOB—adipose tissue—breast cancer	0.000468	0.014	CbGeAlD
Amphetamine—SLC22A3—female reproductive system—breast cancer	0.000465	0.0139	CbGeAlD
Amphetamine—SLC22A3—adrenal gland—breast cancer	0.000454	0.0135	CbGeAlD
Amphetamine—SLC6A4—female reproductive system—breast cancer	0.000452	0.0135	CbGeAlD
Amphetamine—SLC22A5—skin of body—breast cancer	0.000433	0.0129	CbGeAlD
Amphetamine—MAOB—female reproductive system—breast cancer	0.00043	0.0128	CbGeAlD
Amphetamine—SLC22A3—female gonad—breast cancer	0.000423	0.0126	CbGeAlD
Amphetamine—MAOB—adrenal gland—breast cancer	0.00042	0.0125	CbGeAlD
Amphetamine—SLC22A5—endometrium—breast cancer	0.000408	0.0122	CbGeAlD
Amphetamine—Pseudoephedrine—IL2—breast cancer	0.000405	0.137	CrCbGaD
Amphetamine—SLC6A2—female reproductive system—breast cancer	0.000398	0.0119	CbGeAlD
Amphetamine—DRD2—pituitary gland—breast cancer	0.000396	0.0118	CbGeAlD
Amphetamine—SLC22A3—endocrine gland—breast cancer	0.000393	0.0117	CbGeAlD
Amphetamine—MAOB—female gonad—breast cancer	0.000391	0.0117	CbGeAlD
Amphetamine—SLC6A2—adrenal gland—breast cancer	0.000389	0.0116	CbGeAlD
Amphetamine—SLC6A4—endocrine gland—breast cancer	0.000383	0.0114	CbGeAlD
Amphetamine—SLC18A2—lymph node—breast cancer	0.000382	0.0114	CbGeAlD
Amphetamine—SLC22A5—pituitary gland—breast cancer	0.000369	0.011	CbGeAlD
Amphetamine—SLC22A5—adipose tissue—breast cancer	0.000368	0.011	CbGeAlD
Amphetamine—MAOB—endocrine gland—breast cancer	0.000364	0.0109	CbGeAlD
Amphetamine—SLC22A5—female reproductive system—breast cancer	0.000338	0.0101	CbGeAlD
Amphetamine—SLC6A2—endocrine gland—breast cancer	0.000337	0.0101	CbGeAlD
Amphetamine—SLC22A5—adrenal gland—breast cancer	0.00033	0.00984	CbGeAlD
Amphetamine—Ephedrine—ACHE—breast cancer	0.000316	0.107	CrCbGaD
Amphetamine—SLC22A5—female gonad—breast cancer	0.000308	0.00918	CbGeAlD
Amphetamine—DRD2—endocrine gland—breast cancer	0.000307	0.00916	CbGeAlD
Amphetamine—SLC22A3—lymph node—breast cancer	0.000272	0.00811	CbGeAlD
Amphetamine—Lacosamide—SCN10A—breast cancer	0.000261	0.0879	CrCbGaD
Amphetamine—MAOB—lymph node—breast cancer	0.000252	0.00751	CbGeAlD
Amphetamine—Lacosamide—CA9—breast cancer	0.000238	0.0804	CrCbGaD
Amphetamine—SLC6A2—lymph node—breast cancer	0.000233	0.00695	CbGeAlD
Amphetamine—CYP2D6—female reproductive system—breast cancer	0.000218	0.00651	CbGeAlD
Amphetamine—CYP2D6—female gonad—breast cancer	0.000198	0.00592	CbGeAlD
Amphetamine—SLC22A5—lymph node—breast cancer	0.000198	0.0059	CbGeAlD
Amphetamine—Ephedrine—BCHE—breast cancer	0.000186	0.0627	CrCbGaD
Amphetamine—CYP2D6—endocrine gland—breast cancer	0.000185	0.00551	CbGeAlD
Amphetamine—Pseudoephedrine—TNF—breast cancer	0.000137	0.0461	CrCbGaD
Amphetamine—Phenformin—CYP2D6—breast cancer	0.000119	0.0402	CrCbGaD
Amphetamine—Benzyl alcohol—CYP1A1—breast cancer	0.000106	0.0356	CrCbGaD
Amphetamine—Nateglinide—PTGS1—breast cancer	9.92e-05	0.0334	CrCbGaD
Amphetamine—Tranylcypromine—CYP2D6—breast cancer	9.74e-05	0.0328	CrCbGaD
Amphetamine—Abdominal pain upper—Doxorubicin—breast cancer	8.65e-05	0.000579	CcSEcCtD
Amphetamine—Photosensitivity reaction—Methotrexate—breast cancer	8.63e-05	0.000577	CcSEcCtD
Amphetamine—Tachycardia—Paclitaxel—breast cancer	8.59e-05	0.000575	CcSEcCtD
Amphetamine—Urticaria—Mitoxantrone—breast cancer	8.57e-05	0.000574	CcSEcCtD
Amphetamine—Diarrhoea—Thiotepa—breast cancer	8.55e-05	0.000572	CcSEcCtD
Amphetamine—Body temperature increased—Irinotecan—breast cancer	8.53e-05	0.000571	CcSEcCtD
Amphetamine—Abdominal pain—Irinotecan—breast cancer	8.53e-05	0.000571	CcSEcCtD
Amphetamine—Abdominal pain—Mitoxantrone—breast cancer	8.53e-05	0.000571	CcSEcCtD
Amphetamine—Body temperature increased—Mitoxantrone—breast cancer	8.53e-05	0.000571	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Doxorubicin—breast cancer	8.53e-05	0.000571	CcSEcCtD
Amphetamine—Hyperhidrosis—Paclitaxel—breast cancer	8.51e-05	0.000569	CcSEcCtD
Amphetamine—Depression—Methotrexate—breast cancer	8.41e-05	0.000562	CcSEcCtD
Amphetamine—Anorexia—Paclitaxel—breast cancer	8.39e-05	0.000561	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Methotrexate—breast cancer	8.36e-05	0.000559	CcSEcCtD
Amphetamine—Tranylcypromine—CYP3A4—breast cancer	8.35e-05	0.0282	CrCbGaD
Amphetamine—Vomiting—Vinorelbine—breast cancer	8.32e-05	0.000557	CcSEcCtD
Amphetamine—Body temperature increased—Gemcitabine—breast cancer	8.31e-05	0.000556	CcSEcCtD
Amphetamine—Tremor—Capecitabine—breast cancer	8.29e-05	0.000555	CcSEcCtD
Amphetamine—Dizziness—Thiotepa—breast cancer	8.26e-05	0.000553	CcSEcCtD
Amphetamine—Rash—Vinorelbine—breast cancer	8.25e-05	0.000552	CcSEcCtD
Amphetamine—Dermatitis—Vinorelbine—breast cancer	8.24e-05	0.000551	CcSEcCtD
Amphetamine—Urticaria—Fluorouracil—breast cancer	8.21e-05	0.000549	CcSEcCtD
Amphetamine—Headache—Vinorelbine—breast cancer	8.2e-05	0.000548	CcSEcCtD
Amphetamine—Body temperature increased—Fluorouracil—breast cancer	8.17e-05	0.000547	CcSEcCtD
Amphetamine—Phentermine—CYP2D6—breast cancer	8.16e-05	0.0275	CrCbGaD
Amphetamine—Sweating—Methotrexate—breast cancer	8.08e-05	0.000541	CcSEcCtD
Amphetamine—Palpitations—Docetaxel—breast cancer	8.08e-05	0.00054	CcSEcCtD
Amphetamine—Photosensitivity reaction—Epirubicin—breast cancer	8.08e-05	0.00054	CcSEcCtD
Amphetamine—Weight decreased—Epirubicin—breast cancer	8.01e-05	0.000536	CcSEcCtD
Amphetamine—Insomnia—Paclitaxel—breast cancer	7.96e-05	0.000533	CcSEcCtD
Amphetamine—Hypersensitivity—Mitoxantrone—breast cancer	7.95e-05	0.000532	CcSEcCtD
Amphetamine—Hypersensitivity—Irinotecan—breast cancer	7.95e-05	0.000532	CcSEcCtD
Amphetamine—Vomiting—Thiotepa—breast cancer	7.95e-05	0.000532	CcSEcCtD
Amphetamine—Convulsion—Docetaxel—breast cancer	7.92e-05	0.00053	CcSEcCtD
Amphetamine—Hypertension—Docetaxel—breast cancer	7.89e-05	0.000528	CcSEcCtD
Amphetamine—Rash—Thiotepa—breast cancer	7.88e-05	0.000527	CcSEcCtD
Amphetamine—Dermatitis—Thiotepa—breast cancer	7.87e-05	0.000527	CcSEcCtD
Amphetamine—Benzyl alcohol—CYP2D6—breast cancer	7.87e-05	0.0265	CrCbGaD
Amphetamine—Dyspnoea—Paclitaxel—breast cancer	7.85e-05	0.000525	CcSEcCtD
Amphetamine—Headache—Thiotepa—breast cancer	7.83e-05	0.000524	CcSEcCtD
Amphetamine—Somnolence—Paclitaxel—breast cancer	7.83e-05	0.000523	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Epirubicin—breast cancer	7.82e-05	0.000523	CcSEcCtD
Amphetamine—Palpitations—Capecitabine—breast cancer	7.82e-05	0.000523	CcSEcCtD
Amphetamine—Dextroamphetamine—CYP2D6—breast cancer	7.79e-05	0.0262	CrCbGaD
Amphetamine—Chest pain—Docetaxel—breast cancer	7.78e-05	0.000521	CcSEcCtD
Amphetamine—Nausea—Vinorelbine—breast cancer	7.77e-05	0.00052	CcSEcCtD
Amphetamine—Dyspepsia—Paclitaxel—breast cancer	7.75e-05	0.000518	CcSEcCtD
Amphetamine—Asthenia—Irinotecan—breast cancer	7.74e-05	0.000518	CcSEcCtD
Amphetamine—Asthenia—Mitoxantrone—breast cancer	7.74e-05	0.000518	CcSEcCtD
Amphetamine—Pseudoephedrine—CYP2D6—breast cancer	7.74e-05	0.0261	CrCbGaD
Amphetamine—Urinary tract infection—Epirubicin—breast cancer	7.67e-05	0.000513	CcSEcCtD
Amphetamine—Decreased appetite—Paclitaxel—breast cancer	7.65e-05	0.000512	CcSEcCtD
Amphetamine—Hypertension—Capecitabine—breast cancer	7.64e-05	0.000511	CcSEcCtD
Amphetamine—Hypersensitivity—Fluorouracil—breast cancer	7.62e-05	0.000509	CcSEcCtD
Amphetamine—Dry mouth—Docetaxel—breast cancer	7.61e-05	0.000509	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Paclitaxel—breast cancer	7.6e-05	0.000508	CcSEcCtD
Amphetamine—Fatigue—Paclitaxel—breast cancer	7.59e-05	0.000508	CcSEcCtD
Amphetamine—Sweating—Epirubicin—breast cancer	7.56e-05	0.000506	CcSEcCtD
Amphetamine—Selegiline—CYP2D6—breast cancer	7.55e-05	0.0255	CrCbGaD
Amphetamine—Asthenia—Gemcitabine—breast cancer	7.54e-05	0.000505	CcSEcCtD
Amphetamine—Chest pain—Capecitabine—breast cancer	7.54e-05	0.000504	CcSEcCtD
Amphetamine—Constipation—Paclitaxel—breast cancer	7.53e-05	0.000504	CcSEcCtD
Amphetamine—Anxiety—Capecitabine—breast cancer	7.51e-05	0.000502	CcSEcCtD
Amphetamine—Photosensitivity reaction—Doxorubicin—breast cancer	7.47e-05	0.0005	CcSEcCtD
Amphetamine—Anaphylactic shock—Docetaxel—breast cancer	7.46e-05	0.000499	CcSEcCtD
Amphetamine—Nausea—Thiotepa—breast cancer	7.42e-05	0.000497	CcSEcCtD
Amphetamine—Infection—Docetaxel—breast cancer	7.41e-05	0.000496	CcSEcCtD
Amphetamine—Weight decreased—Doxorubicin—breast cancer	7.41e-05	0.000496	CcSEcCtD
Amphetamine—Diarrhoea—Mitoxantrone—breast cancer	7.38e-05	0.000494	CcSEcCtD
Amphetamine—Diarrhoea—Irinotecan—breast cancer	7.38e-05	0.000494	CcSEcCtD
Amphetamine—Dry mouth—Capecitabine—breast cancer	7.37e-05	0.000493	CcSEcCtD
Amphetamine—Tachycardia—Docetaxel—breast cancer	7.28e-05	0.000487	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	7.24e-05	0.000484	CcSEcCtD
Amphetamine—Gastrointestinal pain—Paclitaxel—breast cancer	7.2e-05	0.000481	CcSEcCtD
Amphetamine—Diarrhoea—Gemcitabine—breast cancer	7.19e-05	0.000481	CcSEcCtD
Amphetamine—Infection—Capecitabine—breast cancer	7.18e-05	0.00048	CcSEcCtD
Amphetamine—Erythema multiforme—Methotrexate—breast cancer	7.16e-05	0.000479	CcSEcCtD
Amphetamine—Dizziness—Irinotecan—breast cancer	7.14e-05	0.000477	CcSEcCtD
Amphetamine—Anorexia—Docetaxel—breast cancer	7.11e-05	0.000476	CcSEcCtD
Amphetamine—Urinary tract infection—Doxorubicin—breast cancer	7.1e-05	0.000475	CcSEcCtD
Amphetamine—Diarrhoea—Fluorouracil—breast cancer	7.07e-05	0.000473	CcSEcCtD
Amphetamine—Tachycardia—Capecitabine—breast cancer	7.05e-05	0.000472	CcSEcCtD
Amphetamine—Sweating—Doxorubicin—breast cancer	7e-05	0.000468	CcSEcCtD
Amphetamine—Urticaria—Paclitaxel—breast cancer	6.99e-05	0.000468	CcSEcCtD
Amphetamine—Hyperhidrosis—Capecitabine—breast cancer	6.98e-05	0.000467	CcSEcCtD
Amphetamine—Body temperature increased—Paclitaxel—breast cancer	6.96e-05	0.000465	CcSEcCtD
Amphetamine—Abdominal pain—Paclitaxel—breast cancer	6.96e-05	0.000465	CcSEcCtD
Amphetamine—Anorexia—Capecitabine—breast cancer	6.89e-05	0.000461	CcSEcCtD
Amphetamine—Vomiting—Irinotecan—breast cancer	6.86e-05	0.000459	CcSEcCtD
Amphetamine—Vomiting—Mitoxantrone—breast cancer	6.86e-05	0.000459	CcSEcCtD
Amphetamine—Dizziness—Fluorouracil—breast cancer	6.84e-05	0.000457	CcSEcCtD
Amphetamine—Rash—Irinotecan—breast cancer	6.81e-05	0.000455	CcSEcCtD
Amphetamine—Rash—Mitoxantrone—breast cancer	6.81e-05	0.000455	CcSEcCtD
Amphetamine—Dermatitis—Irinotecan—breast cancer	6.8e-05	0.000455	CcSEcCtD
Amphetamine—Dermatitis—Mitoxantrone—breast cancer	6.8e-05	0.000455	CcSEcCtD
Amphetamine—Headache—Mitoxantrone—breast cancer	6.76e-05	0.000452	CcSEcCtD
Amphetamine—Headache—Irinotecan—breast cancer	6.76e-05	0.000452	CcSEcCtD
Amphetamine—Nateglinide—CYP2D6—breast cancer	6.75e-05	0.0228	CrCbGaD
Amphetamine—Benzyl alcohol—CYP3A4—breast cancer	6.75e-05	0.0228	CrCbGaD
Amphetamine—Insomnia—Docetaxel—breast cancer	6.75e-05	0.000451	CcSEcCtD
Amphetamine—Erythema multiforme—Epirubicin—breast cancer	6.7e-05	0.000448	CcSEcCtD
Amphetamine—Vomiting—Gemcitabine—breast cancer	6.68e-05	0.000447	CcSEcCtD
Amphetamine—Dyspnoea—Docetaxel—breast cancer	6.65e-05	0.000445	CcSEcCtD
Amphetamine—Somnolence—Docetaxel—breast cancer	6.63e-05	0.000444	CcSEcCtD
Amphetamine—Rash—Gemcitabine—breast cancer	6.63e-05	0.000443	CcSEcCtD
Amphetamine—Dermatitis—Gemcitabine—breast cancer	6.62e-05	0.000443	CcSEcCtD
Amphetamine—Headache—Gemcitabine—breast cancer	6.59e-05	0.000441	CcSEcCtD
Amphetamine—Vomiting—Fluorouracil—breast cancer	6.57e-05	0.00044	CcSEcCtD
Amphetamine—Dyspepsia—Docetaxel—breast cancer	6.57e-05	0.000439	CcSEcCtD
Amphetamine—Insomnia—Capecitabine—breast cancer	6.53e-05	0.000437	CcSEcCtD
Amphetamine—Rash—Fluorouracil—breast cancer	6.52e-05	0.000436	CcSEcCtD
Amphetamine—Dermatitis—Fluorouracil—breast cancer	6.51e-05	0.000436	CcSEcCtD
Amphetamine—Decreased appetite—Docetaxel—breast cancer	6.49e-05	0.000434	CcSEcCtD
Amphetamine—Hypersensitivity—Paclitaxel—breast cancer	6.49e-05	0.000434	CcSEcCtD
Amphetamine—Selegiline—CYP3A4—breast cancer	6.48e-05	0.0218	CrCbGaD
Amphetamine—Headache—Fluorouracil—breast cancer	6.48e-05	0.000433	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Docetaxel—breast cancer	6.44e-05	0.000431	CcSEcCtD
Amphetamine—Dyspnoea—Capecitabine—breast cancer	6.44e-05	0.000431	CcSEcCtD
Amphetamine—Fatigue—Docetaxel—breast cancer	6.43e-05	0.00043	CcSEcCtD
Amphetamine—Nausea—Mitoxantrone—breast cancer	6.41e-05	0.000429	CcSEcCtD
Amphetamine—Nausea—Irinotecan—breast cancer	6.41e-05	0.000429	CcSEcCtD
Amphetamine—Constipation—Docetaxel—breast cancer	6.38e-05	0.000427	CcSEcCtD
Amphetamine—Dyspepsia—Capecitabine—breast cancer	6.36e-05	0.000425	CcSEcCtD
Amphetamine—Asthenia—Paclitaxel—breast cancer	6.32e-05	0.000422	CcSEcCtD
Amphetamine—Decreased appetite—Capecitabine—breast cancer	6.28e-05	0.00042	CcSEcCtD
Amphetamine—Nausea—Gemcitabine—breast cancer	6.24e-05	0.000418	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Capecitabine—breast cancer	6.24e-05	0.000417	CcSEcCtD
Amphetamine—Fatigue—Capecitabine—breast cancer	6.23e-05	0.000417	CcSEcCtD
Amphetamine—Erythema multiforme—Doxorubicin—breast cancer	6.2e-05	0.000415	CcSEcCtD
Amphetamine—Constipation—Capecitabine—breast cancer	6.18e-05	0.000413	CcSEcCtD
Amphetamine—Nausea—Fluorouracil—breast cancer	6.14e-05	0.000411	CcSEcCtD
Amphetamine—Gastrointestinal pain—Docetaxel—breast cancer	6.1e-05	0.000408	CcSEcCtD
Amphetamine—Tension—Epirubicin—breast cancer	6.05e-05	0.000405	CcSEcCtD
Amphetamine—Diarrhoea—Paclitaxel—breast cancer	6.02e-05	0.000403	CcSEcCtD
Amphetamine—Nervousness—Epirubicin—breast cancer	5.99e-05	0.000401	CcSEcCtD
Amphetamine—Gastrointestinal pain—Capecitabine—breast cancer	5.91e-05	0.000395	CcSEcCtD
Amphetamine—Body temperature increased—Docetaxel—breast cancer	5.9e-05	0.000395	CcSEcCtD
Amphetamine—Abdominal pain—Docetaxel—breast cancer	5.9e-05	0.000395	CcSEcCtD
Amphetamine—Dizziness—Paclitaxel—breast cancer	5.82e-05	0.000389	CcSEcCtD
Amphetamine—Methamphetamine—CYP2D6—breast cancer	5.81e-05	0.0196	CrCbGaD
Amphetamine—Nateglinide—CYP3A4—breast cancer	5.79e-05	0.0195	CrCbGaD
Amphetamine—Urticaria—Capecitabine—breast cancer	5.74e-05	0.000384	CcSEcCtD
Amphetamine—Body temperature increased—Capecitabine—breast cancer	5.71e-05	0.000382	CcSEcCtD
Amphetamine—Abdominal pain—Capecitabine—breast cancer	5.71e-05	0.000382	CcSEcCtD
Amphetamine—Convulsion—Methotrexate—breast cancer	5.71e-05	0.000382	CcSEcCtD
Amphetamine—Phenelzine—CYP3A4—breast cancer	5.71e-05	0.0192	CrCbGaD
Amphetamine—Agitation—Epirubicin—breast cancer	5.67e-05	0.000379	CcSEcCtD
Amphetamine—Chest pain—Methotrexate—breast cancer	5.61e-05	0.000375	CcSEcCtD
Amphetamine—Tension—Doxorubicin—breast cancer	5.6e-05	0.000375	CcSEcCtD
Amphetamine—Vomiting—Paclitaxel—breast cancer	5.6e-05	0.000374	CcSEcCtD
Amphetamine—Rash—Paclitaxel—breast cancer	5.55e-05	0.000371	CcSEcCtD
Amphetamine—Dermatitis—Paclitaxel—breast cancer	5.54e-05	0.000371	CcSEcCtD
Amphetamine—Nervousness—Doxorubicin—breast cancer	5.54e-05	0.000371	CcSEcCtD
Amphetamine—Headache—Paclitaxel—breast cancer	5.51e-05	0.000369	CcSEcCtD
Amphetamine—Hypersensitivity—Docetaxel—breast cancer	5.5e-05	0.000368	CcSEcCtD
Amphetamine—Palpitations—Epirubicin—breast cancer	5.45e-05	0.000364	CcSEcCtD
Amphetamine—Selegiline—ABCB1—breast cancer	5.39e-05	0.0182	CrCbGaD
Amphetamine—Anaphylactic shock—Methotrexate—breast cancer	5.38e-05	0.00036	CcSEcCtD
Amphetamine—Asthenia—Docetaxel—breast cancer	5.35e-05	0.000358	CcSEcCtD
Amphetamine—Convulsion—Epirubicin—breast cancer	5.34e-05	0.000357	CcSEcCtD
Amphetamine—Infection—Methotrexate—breast cancer	5.34e-05	0.000357	CcSEcCtD
Amphetamine—Hypertension—Epirubicin—breast cancer	5.32e-05	0.000356	CcSEcCtD
Amphetamine—Hypersensitivity—Capecitabine—breast cancer	5.32e-05	0.000356	CcSEcCtD
Amphetamine—Chest pain—Epirubicin—breast cancer	5.25e-05	0.000351	CcSEcCtD
Amphetamine—Agitation—Doxorubicin—breast cancer	5.24e-05	0.000351	CcSEcCtD
Amphetamine—Anxiety—Epirubicin—breast cancer	5.23e-05	0.00035	CcSEcCtD
Amphetamine—Nausea—Paclitaxel—breast cancer	5.23e-05	0.00035	CcSEcCtD
Amphetamine—Hyperhidrosis—Methotrexate—breast cancer	5.2e-05	0.000348	CcSEcCtD
Amphetamine—Asthenia—Capecitabine—breast cancer	5.18e-05	0.000347	CcSEcCtD
Amphetamine—Dry mouth—Epirubicin—breast cancer	5.13e-05	0.000343	CcSEcCtD
Amphetamine—Anorexia—Methotrexate—breast cancer	5.13e-05	0.000343	CcSEcCtD
Amphetamine—Diarrhoea—Docetaxel—breast cancer	5.1e-05	0.000341	CcSEcCtD
Amphetamine—Nateglinide—ALB—breast cancer	5.05e-05	0.017	CrCbGaD
Amphetamine—Palpitations—Doxorubicin—breast cancer	5.04e-05	0.000337	CcSEcCtD
Amphetamine—Anaphylactic shock—Epirubicin—breast cancer	5.03e-05	0.000337	CcSEcCtD
Amphetamine—Infection—Epirubicin—breast cancer	5e-05	0.000334	CcSEcCtD
Amphetamine—Benzphetamine—CYP3A4—breast cancer	4.95e-05	0.0167	CrCbGaD
Amphetamine—Convulsion—Doxorubicin—breast cancer	4.94e-05	0.000331	CcSEcCtD
Amphetamine—Diarrhoea—Capecitabine—breast cancer	4.94e-05	0.000331	CcSEcCtD
Amphetamine—Dizziness—Docetaxel—breast cancer	4.93e-05	0.00033	CcSEcCtD
Amphetamine—Hypertension—Doxorubicin—breast cancer	4.93e-05	0.000329	CcSEcCtD
Amphetamine—Tachycardia—Epirubicin—breast cancer	4.91e-05	0.000329	CcSEcCtD
Amphetamine—Hyperhidrosis—Epirubicin—breast cancer	4.86e-05	0.000325	CcSEcCtD
Amphetamine—Insomnia—Methotrexate—breast cancer	4.86e-05	0.000325	CcSEcCtD
Amphetamine—Chest pain—Doxorubicin—breast cancer	4.86e-05	0.000325	CcSEcCtD
Amphetamine—Anxiety—Doxorubicin—breast cancer	4.84e-05	0.000324	CcSEcCtD
Amphetamine—Anorexia—Epirubicin—breast cancer	4.8e-05	0.000321	CcSEcCtD
Amphetamine—Dyspnoea—Methotrexate—breast cancer	4.79e-05	0.000321	CcSEcCtD
Amphetamine—Somnolence—Methotrexate—breast cancer	4.78e-05	0.00032	CcSEcCtD
Amphetamine—Dizziness—Capecitabine—breast cancer	4.78e-05	0.00032	CcSEcCtD
Amphetamine—Dry mouth—Doxorubicin—breast cancer	4.75e-05	0.000318	CcSEcCtD
Amphetamine—Vomiting—Docetaxel—breast cancer	4.74e-05	0.000317	CcSEcCtD
Amphetamine—Dyspepsia—Methotrexate—breast cancer	4.73e-05	0.000317	CcSEcCtD
Amphetamine—Rash—Docetaxel—breast cancer	4.7e-05	0.000315	CcSEcCtD
Amphetamine—Dermatitis—Docetaxel—breast cancer	4.7e-05	0.000314	CcSEcCtD
Amphetamine—Decreased appetite—Methotrexate—breast cancer	4.67e-05	0.000313	CcSEcCtD
Amphetamine—Headache—Docetaxel—breast cancer	4.67e-05	0.000313	CcSEcCtD
Amphetamine—Anaphylactic shock—Doxorubicin—breast cancer	4.66e-05	0.000311	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Methotrexate—breast cancer	4.64e-05	0.000311	CcSEcCtD
Amphetamine—Fatigue—Methotrexate—breast cancer	4.64e-05	0.00031	CcSEcCtD
Amphetamine—Infection—Doxorubicin—breast cancer	4.63e-05	0.000309	CcSEcCtD
Amphetamine—Vomiting—Capecitabine—breast cancer	4.59e-05	0.000307	CcSEcCtD
Amphetamine—Rash—Capecitabine—breast cancer	4.55e-05	0.000305	CcSEcCtD
Amphetamine—Insomnia—Epirubicin—breast cancer	4.55e-05	0.000304	CcSEcCtD
Amphetamine—Dermatitis—Capecitabine—breast cancer	4.55e-05	0.000304	CcSEcCtD
Amphetamine—Tachycardia—Doxorubicin—breast cancer	4.54e-05	0.000304	CcSEcCtD
Amphetamine—Headache—Capecitabine—breast cancer	4.53e-05	0.000303	CcSEcCtD
Amphetamine—Hyperhidrosis—Doxorubicin—breast cancer	4.5e-05	0.000301	CcSEcCtD
Amphetamine—Dyspnoea—Epirubicin—breast cancer	4.49e-05	0.0003	CcSEcCtD
Amphetamine—Somnolence—Epirubicin—breast cancer	4.47e-05	0.000299	CcSEcCtD
Amphetamine—Anorexia—Doxorubicin—breast cancer	4.44e-05	0.000297	CcSEcCtD
Amphetamine—Nausea—Docetaxel—breast cancer	4.43e-05	0.000296	CcSEcCtD
Amphetamine—Dyspepsia—Epirubicin—breast cancer	4.43e-05	0.000296	CcSEcCtD
Amphetamine—Gastrointestinal pain—Methotrexate—breast cancer	4.4e-05	0.000294	CcSEcCtD
Amphetamine—Decreased appetite—Epirubicin—breast cancer	4.37e-05	0.000293	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Epirubicin—breast cancer	4.34e-05	0.000291	CcSEcCtD
Amphetamine—Fatigue—Epirubicin—breast cancer	4.34e-05	0.00029	CcSEcCtD
Amphetamine—Constipation—Epirubicin—breast cancer	4.3e-05	0.000288	CcSEcCtD
Amphetamine—Nausea—Capecitabine—breast cancer	4.29e-05	0.000287	CcSEcCtD
Amphetamine—Urticaria—Methotrexate—breast cancer	4.27e-05	0.000286	CcSEcCtD
Amphetamine—Abdominal pain—Methotrexate—breast cancer	4.25e-05	0.000284	CcSEcCtD
Amphetamine—Body temperature increased—Methotrexate—breast cancer	4.25e-05	0.000284	CcSEcCtD
Amphetamine—Insomnia—Doxorubicin—breast cancer	4.21e-05	0.000282	CcSEcCtD
Amphetamine—Dyspnoea—Doxorubicin—breast cancer	4.15e-05	0.000278	CcSEcCtD
Amphetamine—Somnolence—Doxorubicin—breast cancer	4.14e-05	0.000277	CcSEcCtD
Amphetamine—Gastrointestinal pain—Epirubicin—breast cancer	4.12e-05	0.000275	CcSEcCtD
Amphetamine—Dyspepsia—Doxorubicin—breast cancer	4.1e-05	0.000274	CcSEcCtD
Amphetamine—Decreased appetite—Doxorubicin—breast cancer	4.05e-05	0.000271	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Doxorubicin—breast cancer	4.02e-05	0.000269	CcSEcCtD
Amphetamine—Fatigue—Doxorubicin—breast cancer	4.01e-05	0.000269	CcSEcCtD
Amphetamine—Urticaria—Epirubicin—breast cancer	4e-05	0.000267	CcSEcCtD
Amphetamine—Constipation—Doxorubicin—breast cancer	3.98e-05	0.000266	CcSEcCtD
Amphetamine—Abdominal pain—Epirubicin—breast cancer	3.98e-05	0.000266	CcSEcCtD
Amphetamine—Body temperature increased—Epirubicin—breast cancer	3.98e-05	0.000266	CcSEcCtD
Amphetamine—Hypersensitivity—Methotrexate—breast cancer	3.96e-05	0.000265	CcSEcCtD
Amphetamine—Asthenia—Methotrexate—breast cancer	3.86e-05	0.000258	CcSEcCtD
Amphetamine—Gastrointestinal pain—Doxorubicin—breast cancer	3.81e-05	0.000255	CcSEcCtD
Amphetamine—Hypersensitivity—Epirubicin—breast cancer	3.71e-05	0.000248	CcSEcCtD
Amphetamine—Urticaria—Doxorubicin—breast cancer	3.7e-05	0.000247	CcSEcCtD
Amphetamine—Abdominal pain—Doxorubicin—breast cancer	3.68e-05	0.000246	CcSEcCtD
Amphetamine—Body temperature increased—Doxorubicin—breast cancer	3.68e-05	0.000246	CcSEcCtD
Amphetamine—Diarrhoea—Methotrexate—breast cancer	3.68e-05	0.000246	CcSEcCtD
Amphetamine—Asthenia—Epirubicin—breast cancer	3.61e-05	0.000242	CcSEcCtD
Amphetamine—Dizziness—Methotrexate—breast cancer	3.56e-05	0.000238	CcSEcCtD
Amphetamine—Diarrhoea—Epirubicin—breast cancer	3.44e-05	0.00023	CcSEcCtD
Amphetamine—Hypersensitivity—Doxorubicin—breast cancer	3.43e-05	0.000229	CcSEcCtD
Amphetamine—Vomiting—Methotrexate—breast cancer	3.42e-05	0.000229	CcSEcCtD
Amphetamine—Rash—Methotrexate—breast cancer	3.39e-05	0.000227	CcSEcCtD
Amphetamine—Dermatitis—Methotrexate—breast cancer	3.39e-05	0.000227	CcSEcCtD
Amphetamine—Headache—Methotrexate—breast cancer	3.37e-05	0.000225	CcSEcCtD
Amphetamine—Asthenia—Doxorubicin—breast cancer	3.34e-05	0.000223	CcSEcCtD
Amphetamine—Dizziness—Epirubicin—breast cancer	3.33e-05	0.000223	CcSEcCtD
Amphetamine—Vomiting—Epirubicin—breast cancer	3.2e-05	0.000214	CcSEcCtD
Amphetamine—Nausea—Methotrexate—breast cancer	3.19e-05	0.000214	CcSEcCtD
Amphetamine—Diarrhoea—Doxorubicin—breast cancer	3.19e-05	0.000213	CcSEcCtD
Amphetamine—Rash—Epirubicin—breast cancer	3.17e-05	0.000212	CcSEcCtD
Amphetamine—Dermatitis—Epirubicin—breast cancer	3.17e-05	0.000212	CcSEcCtD
Amphetamine—Headache—Epirubicin—breast cancer	3.15e-05	0.000211	CcSEcCtD
Amphetamine—Dizziness—Doxorubicin—breast cancer	3.08e-05	0.000206	CcSEcCtD
Amphetamine—Nausea—Epirubicin—breast cancer	2.99e-05	0.0002	CcSEcCtD
Amphetamine—Vomiting—Doxorubicin—breast cancer	2.96e-05	0.000198	CcSEcCtD
Amphetamine—Rash—Doxorubicin—breast cancer	2.94e-05	0.000196	CcSEcCtD
Amphetamine—Dermatitis—Doxorubicin—breast cancer	2.93e-05	0.000196	CcSEcCtD
Amphetamine—Headache—Doxorubicin—breast cancer	2.92e-05	0.000195	CcSEcCtD
Amphetamine—Nausea—Doxorubicin—breast cancer	2.77e-05	0.000185	CcSEcCtD
Amphetamine—CYP2D6—Metabolism—LDHB—breast cancer	6.57e-06	6.7e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MYC—breast cancer	6.57e-06	6.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VEGFC—breast cancer	6.55e-06	6.69e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—breast cancer	6.55e-06	6.69e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JAG2—breast cancer	6.45e-06	6.59e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EGFR—breast cancer	6.42e-06	6.56e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—FASN—breast cancer	6.4e-06	6.54e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—BCHE—breast cancer	6.38e-06	6.51e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—WNT1—breast cancer	6.36e-06	6.49e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PLA2G4A—breast cancer	6.34e-06	6.48e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC5A5—breast cancer	6.3e-06	6.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CSF2—breast cancer	6.27e-06	6.4e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CD—breast cancer	6.25e-06	6.38e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCC1—breast cancer	6.23e-06	6.35e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTA3—breast cancer	6.23e-06	6.35e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMMR—breast cancer	6.23e-06	6.35e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—breast cancer	6.17e-06	6.3e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC2A1—breast cancer	6.08e-06	6.21e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NQO1—breast cancer	6.08e-06	6.21e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KRAS—breast cancer	6.07e-06	6.19e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARGC1B—breast cancer	6.03e-06	6.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH4—breast cancer	6.03e-06	6.15e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CG—breast cancer	6.01e-06	6.14e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GZMB—breast cancer	5.99e-06	6.12e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP3A4—breast cancer	5.93e-06	6.06e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NOS3—breast cancer	5.9e-06	6.02e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP1B1—breast cancer	5.83e-06	5.95e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGTR2—breast cancer	5.82e-06	5.94e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL2—breast cancer	5.82e-06	5.94e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTHLH—breast cancer	5.75e-06	5.87e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BMP2—breast cancer	5.75e-06	5.87e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HSP90AA1—breast cancer	5.72e-06	5.84e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTA4—breast cancer	5.69e-06	5.81e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CA9—breast cancer	5.69e-06	5.81e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CA—breast cancer	5.57e-06	5.69e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EDNRB—breast cancer	5.57e-06	5.69e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NCOA1—breast cancer	5.56e-06	5.68e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTA2—breast cancer	5.55e-06	5.66e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX2—breast cancer	5.55e-06	5.66e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PGR—breast cancer	5.51e-06	5.63e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—THBS1—breast cancer	5.49e-06	5.6e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP19A1—breast cancer	5.48e-06	5.6e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—STK11—breast cancer	5.48e-06	5.6e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SULT1A1—breast cancer	5.48e-06	5.59e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX4—breast cancer	5.48e-06	5.59e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CB—breast cancer	5.45e-06	5.56e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—breast cancer	5.4e-06	5.51e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TP53—breast cancer	5.39e-06	5.5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—IDH1—breast cancer	5.35e-06	5.46e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTA1—breast cancer	5.35e-06	5.46e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NAT2—breast cancer	5.29e-06	5.4e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CD—breast cancer	5.29e-06	5.4e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FLT1—breast cancer	5.24e-06	5.35e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—breast cancer	5.22e-06	5.33e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SQSTM1—breast cancer	5.21e-06	5.32e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF3—breast cancer	5.21e-06	5.32e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CG—breast cancer	5.19e-06	5.3e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HRAS—breast cancer	5.16e-06	5.26e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JAG1—breast cancer	5.15e-06	5.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH3—breast cancer	5.13e-06	5.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PARP1—breast cancer	5.13e-06	5.23e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—COMT—breast cancer	5.1e-06	5.2e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTP1—breast cancer	5.07e-06	5.18e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALCA—breast cancer	5.06e-06	5.17e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HMOX1—breast cancer	5e-06	5.11e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RPS6—breast cancer	5e-06	5.11e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ITPR1—breast cancer	4.99e-06	5.1e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NOS3—breast cancer	4.99e-06	5.09e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF4—breast cancer	4.96e-06	5.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCR4—breast cancer	4.95e-06	5.05e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL12—breast cancer	4.95e-06	5.05e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—breast cancer	4.94e-06	5.04e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PAK1—breast cancer	4.85e-06	4.95e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCB1—breast cancer	4.8e-06	4.9e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TCF7L2—breast cancer	4.77e-06	4.87e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT2—breast cancer	4.75e-06	4.84e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TYMS—breast cancer	4.72e-06	4.81e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CG—breast cancer	4.71e-06	4.81e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTEN—breast cancer	4.71e-06	4.8e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTM1—breast cancer	4.66e-06	4.76e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NCOR1—breast cancer	4.66e-06	4.76e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PLA2G4A—breast cancer	4.66e-06	4.76e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DPYD—breast cancer	4.64e-06	4.74e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MED12—breast cancer	4.64e-06	4.74e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CB—breast cancer	4.61e-06	4.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH2—breast cancer	4.6e-06	4.69e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HSP90AA1—breast cancer	4.6e-06	4.69e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALDOA—breast cancer	4.57e-06	4.66e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—breast cancer	4.56e-06	4.66e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CD—breast cancer	4.56e-06	4.66e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AKT1—breast cancer	4.55e-06	4.65e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGTR1—breast cancer	4.47e-06	4.57e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRL—breast cancer	4.47e-06	4.57e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GPX1—breast cancer	4.46e-06	4.56e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NCOA3—breast cancer	4.44e-06	4.53e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP1A1—breast cancer	4.42e-06	4.51e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STK11—breast cancer	4.41e-06	4.5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADAM10—breast cancer	4.41e-06	4.5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC2A2—breast cancer	4.4e-06	4.5e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ERCC2—breast cancer	4.38e-06	4.47e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLG—breast cancer	4.36e-06	4.45e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CPT1A—breast cancer	4.32e-06	4.4e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCG2—breast cancer	4.32e-06	4.4e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTR—breast cancer	4.32e-06	4.4e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT2—breast cancer	4.31e-06	4.4e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF10—breast cancer	4.29e-06	4.38e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HPGDS—breast cancer	4.23e-06	4.32e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HBA1—breast cancer	4.21e-06	4.29e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CD—breast cancer	4.14e-06	4.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDGFA—breast cancer	4.14e-06	4.22e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—breast cancer	4.12e-06	4.21e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ACHE—breast cancer	4.1e-06	4.19e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTT1—breast cancer	4.1e-06	4.19e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFBR2—breast cancer	4.08e-06	4.16e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ITPR1—breast cancer	4.01e-06	4.1e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STAT5A—breast cancer	3.99e-06	4.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ERBB4—breast cancer	3.99e-06	4.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP3—breast cancer	3.99e-06	4.07e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTEN—breast cancer	3.98e-06	4.06e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CB—breast cancer	3.98e-06	4.06e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP17A1—breast cancer	3.89e-06	3.97e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SMAD4—breast cancer	3.86e-06	3.94e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ENO1—breast cancer	3.85e-06	3.93e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS1—breast cancer	3.85e-06	3.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF1R—breast cancer	3.84e-06	3.92e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL8—breast cancer	3.82e-06	3.9e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAV1—breast cancer	3.8e-06	3.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HES1—breast cancer	3.77e-06	3.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLA2G4A—breast cancer	3.75e-06	3.83e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NCOR1—breast cancer	3.75e-06	3.83e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CSF2—breast cancer	3.71e-06	3.78e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF1—breast cancer	3.71e-06	3.78e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NCOA2—breast cancer	3.7e-06	3.78e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—RAF1—breast cancer	3.7e-06	3.77e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NRG1—breast cancer	3.68e-06	3.76e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—H2AFX—breast cancer	3.65e-06	3.73e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—IL2—breast cancer	3.65e-06	3.73e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—E2F1—breast cancer	3.63e-06	3.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CB—breast cancer	3.61e-06	3.68e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FASN—breast cancer	3.59e-06	3.67e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—BCHE—breast cancer	3.58e-06	3.65e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC5A5—breast cancer	3.53e-06	3.61e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SPP1—breast cancer	3.48e-06	3.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL8—breast cancer	3.47e-06	3.54e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CG—breast cancer	3.46e-06	3.53e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ERBB3—breast cancer	3.45e-06	3.52e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGFR2—breast cancer	3.44e-06	3.51e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NQO1—breast cancer	3.41e-06	3.48e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC2A1—breast cancer	3.41e-06	3.48e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP3A4—breast cancer	3.33e-06	3.4e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CA—breast cancer	3.32e-06	3.39e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL2—breast cancer	3.32e-06	3.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TERT—breast cancer	3.3e-06	3.37e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP1B1—breast cancer	3.27e-06	3.34e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.21e-06	3.27e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGFR1—breast cancer	3.21e-06	3.27e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HIF1A—breast cancer	3.16e-06	3.22e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NCOA1—breast cancer	3.12e-06	3.18e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LEP—breast cancer	3.08e-06	3.15e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—STK11—breast cancer	3.07e-06	3.14e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP19A1—breast cancer	3.07e-06	3.14e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CAV1—breast cancer	3.06e-06	3.12e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CD—breast cancer	3.04e-06	3.11e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KDR—breast cancer	3.02e-06	3.08e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—breast cancer	3e-06	3.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ESR1—breast cancer	2.94e-06	3.01e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FN1—breast cancer	2.91e-06	2.97e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NOS3—breast cancer	2.87e-06	2.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NFKBIA—breast cancer	2.87e-06	2.93e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—COMT—breast cancer	2.86e-06	2.92e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH1—breast cancer	2.85e-06	2.9e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTP1—breast cancer	2.85e-06	2.9e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CA—breast cancer	2.81e-06	2.87e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMOX1—breast cancer	2.81e-06	2.86e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ITPR1—breast cancer	2.8e-06	2.86e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KIT—breast cancer	2.78e-06	2.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APC—breast cancer	2.78e-06	2.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CG—breast cancer	2.78e-06	2.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EGF—breast cancer	2.75e-06	2.81e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AKT1—breast cancer	2.71e-06	2.77e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCB1—breast cancer	2.69e-06	2.75e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MAPK3—breast cancer	2.67e-06	2.72e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CB—breast cancer	2.65e-06	2.71e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TYMS—breast cancer	2.64e-06	2.7e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—breast cancer	2.63e-06	2.68e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BRAF—breast cancer	2.62e-06	2.67e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NCOR1—breast cancer	2.61e-06	2.67e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTM1—breast cancer	2.61e-06	2.67e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.61e-06	2.67e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF1—breast cancer	2.55e-06	2.6e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT2—breast cancer	2.55e-06	2.6e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—EGFR—breast cancer	2.54e-06	2.59e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX1—breast cancer	2.5e-06	2.56e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP1A1—breast cancer	2.48e-06	2.53e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ERCC2—breast cancer	2.46e-06	2.51e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CD—breast cancer	2.45e-06	2.5e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	2.42e-06	2.47e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SERPINE1—breast cancer	2.42e-06	2.47e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—KRAS—breast cancer	2.4e-06	2.44e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—breast cancer	2.31e-06	2.36e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOS3—breast cancer	2.31e-06	2.36e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKT1—breast cancer	2.29e-06	2.34e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTEN—breast cancer	2.29e-06	2.34e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CA—breast cancer	2.2e-06	2.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MDM2—breast cancer	2.19e-06	2.24e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RAF1—breast cancer	2.18e-06	2.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RELA—breast cancer	2.17e-06	2.22e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ERBB2—breast cancer	2.16e-06	2.21e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CB—breast cancer	2.13e-06	2.18e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MTOR—breast cancer	2.13e-06	2.18e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAV1—breast cancer	2.13e-06	2.18e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL8—breast cancer	2.05e-06	2.09e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HRAS—breast cancer	2.04e-06	2.08e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDKN1B—breast cancer	2e-06	2.04e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT1—breast cancer	1.98e-06	2.02e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CASP3—breast cancer	1.96e-06	2e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL2—breast cancer	1.96e-06	2e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—breast cancer	1.95e-06	1.99e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.94e-06	1.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCND1—breast cancer	1.91e-06	1.95e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JUN—breast cancer	1.91e-06	1.94e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.89e-06	1.93e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—breast cancer	1.85e-06	1.89e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.85e-06	1.89e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTEN—breast cancer	1.84e-06	1.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK8—breast cancer	1.8e-06	1.84e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT1—breast cancer	1.8e-06	1.83e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SRC—breast cancer	1.71e-06	1.74e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.71e-06	1.74e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—breast cancer	1.68e-06	1.72e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VEGFA—breast cancer	1.66e-06	1.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STAT3—breast cancer	1.65e-06	1.68e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CA—breast cancer	1.62e-06	1.65e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NOS3—breast cancer	1.61e-06	1.65e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK3—breast cancer	1.57e-06	1.61e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MYC—breast cancer	1.53e-06	1.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—breast cancer	1.53e-06	1.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EGFR—breast cancer	1.5e-06	1.53e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.49e-06	1.52e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—breast cancer	1.47e-06	1.5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KRAS—breast cancer	1.41e-06	1.44e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKT1—breast cancer	1.32e-06	1.35e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.3e-06	1.33e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTEN—breast cancer	1.29e-06	1.31e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TP53—breast cancer	1.26e-06	1.28e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRAS—breast cancer	1.2e-06	1.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—breast cancer	1.15e-06	1.17e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT1—breast cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CA—breast cancer	9.07e-07	9.26e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKT1—breast cancer	7.41e-07	7.56e-06	CbGpPWpGaD
